Inhibition of VEGF-A prevents the angiogenic switch and results in increased survival of Apc super(+...
Inhibition of VEGF-A prevents the angiogenic switch and results in increased survival of Apc super(+/min) mice
About this item
Full title
Inhibition of VEGF-A prevents the angiogenic switch and results in increased survival of Apc super(+/min) mice
Author / Creator
Journal title
Proceedings of the National Academy of Sciences - PNAS, 2007-06, Vol.104 (25), p.10625-10630
Language
English
Formats
More information
Scope and Contents
Contents
Anti-VEGF-A monoclonal antibodies, in combination with chemotherapy, result in a survival benefit in patients with metastatic colorectal and non-small cell lung cancer, but little is known regarding the impact of anti-VEGF-A therapy on benign or premalignant tumors. The Apc super(+/min) mice have been widely used as a model recapitulating early int...
Alternative Titles
Full title
Inhibition of VEGF-A prevents the angiogenic switch and results in increased survival of Apc super(+/min) mice
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_19692210
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_19692210
Other Identifiers
ISSN
0027-8424
E-ISSN
1091-6490
How to access this item
Log in as a Library member
